Eli Lilly and Company (LLY) financial statements (2020 and earlier)

Company profile

Business Address LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
State of Incorp. IN
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,4398,0868,0346,0394,4524,8275,397
Cash and cash equivalents2,3387,9986,5364,5823,6663,8723,830
Short-term investments101881,4981,4577859551,567
Receivables4,5475,2474,5464,0293,5133,2354,023
Inventory, net of allowances, customer advances and progress billings3,1914,1124,4583,5623,4462,7402,929
Inventory3,1914,1124,4583,5623,4462,7402,929
Prepaid expense2,5392,1471,448735604812756
Other undisclosed current assets994958716737559567 
Total current assets:13,71020,55019,20215,10112,57412,18013,105
Noncurrent Assets
Operating lease, right-of-use asset532
Property, plant and equipment7,873    7,9647,976
Long-term investments and receivables1,9622,0215,6795,2083,6474,5697,625
Long-term investments1,9622,0215,6795,2083,6474,5697,625
Intangible assets, net (including goodwill)10,2977,8698,3998,3319,0754,6424,298
Goodwill3,6794,3484,3703,9734,0401,7581,517
Intangible assets, net (excluding goodwill)6,6183,5214,0294,3585,0352,8842,781
Regulated entity, other noncurrent assets74      
Restricted cash and investments     5,406 
Deferred income tax assets2,573
Other noncurrent assets 1,8922,8741,9142,2212,4182,213
Other undisclosed noncurrent assets2,2662,658   (7,964)(7,942)
Total noncurrent assets:25,57714,43916,95215,45214,94217,03514,169
Other undisclosed assets 8,9208,8278,2538,0547,9647,976
TOTAL ASSETS:39,28643,90844,98138,80635,56937,17835,249
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1533,5223,5322,9133,2032,5112,318
Accounts payable1,4051,4121,4111,3491,3381,1281,119
Employee-related liabilities9161,055998897967759944
Taxes payable16140453311935994254
Interest and dividends payable672651591548539530 
Debt1,4991,1313,7071,93762,6892,025
Deferred tax liabilities    1,467793
Other liabilities2,1892,2132,8322,2212,4602,4732,328
Other undisclosed current liabilities4,9345,0224,4653,9152,5602,0691,453
Total current liabilities:11,77511,88814,53610,9878,23011,2088,917
Noncurrent Liabilities
Long-term debt and lease obligation14,30511,6409,9418,3687,9725,3684,200
Long-term debt, excluding current maturities13,81811,6409,9418,3687,9725,3684,200
Operating lease, liability487
Liabilities, other than long-term debt10,5079,4728,8375,3714,7775,2154,491
Pension and other postretirement defined benefit plans, liabilities1,549
Accounts payable and accrued liabilities3,6073,7253,777689869999 
Accrued income taxes1,079
Deferred income tax liabilities2,188
Liability, pension and other postretirement and postemployment benefits3,6982,9113,5142,4542,1602,563
Other liabilities1,0142,8361,5462,2281,7471,6541,863
Total noncurrent liabilities:24,81221,11118,77713,73912,74910,5838,691
Total liabilities:36,58732,99933,31324,72520,97921,79017,608
Stockholders' equity
Stockholders' equity attributable to parent, including:2,6079,82911,59214,00814,57115,37317,631
Common stock599661688689691695699
Treasury stock, value(61)(69)(76)(81)(90)(91)(94)
Additional paid in capital6,6856,5845,8185,6415,5525,2925,050
Accumulated other comprehensive loss(6,524)(5,729)(5,719)(5,274)(4,581)(3,992)(2,003)
Retained earnings4,92011,39613,89416,04616,01216,48316,992
Other undisclosed stockholders' equity attributable to parent(3,013)(3,013)(3,013)(3,013)(3,013)(3,013)(3,013)
Stockholders' equity attributable to noncontrolling interest921,080767319159
Total stockholders' equity:2,69910,90911,66814,08114,59015,38817,641
TOTAL LIABILITIES AND EQUITY:39,28643,90844,98138,80635,56937,17835,249

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues22,32024,55622,87121,22219,95919,61623,113
Cost of revenue
(Cost of Goods and Services Sold)
(4,721)(6,430)(6,070)(5,655)(5,037)(4,933)(4,908)
Gross profit:17,59818,12616,80115,56714,92214,68318,205
Operating expenses(12,384)(12,421)(13,544)(12,078)(11,697)(12,359)(13,333)
Operating income:5,2145,7053,2583,4893,2242,3244,873
Nonoperating income (expense)2927552(85)101341519
Investment income, nonoperating39016116710987475120
Gain on contract termination      495
Foreign currency transaction loss, before tax   (204)   
Net periodic defined benefits expense (reversal of expense), excluding service cost component210 
Other nonoperating income (expense)345(57)11019634236864
Interest and debt expense(253)242(225)(185)(167)(149)(160)
Other undisclosed income from continuing operations before equity method investments, income taxes     485658
Income from continuing operations before equity method investments, income taxes:5,2536,0223,0853,2193,1583,0005,889
Other undisclosed income (loss) from continuing operations before income taxes13(2,226)(888)155(368)  
Income from continuing operations before income taxes:5,2663,7962,1973,3742,7903,0005,889
Income tax expense(628)(564)(2,402)(636)(382)(610)(1,205)
Income (loss) from continuing operations:4,6383,232(204)2,7382,4082,3914,685
Income from discontinued operations3,681      
Net income (loss) available to common stockholders, diluted:8,3183,232(204)2,7382,4082,3914,685

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):8,3183,232(204)2,7382,4082,3914,685
Other comprehensive income (loss)(783)84175(645)(589)(1,989)1,794
Comprehensive income (loss):7,5353,316(30)2,0931,8204016,479
Comprehensive income (loss), net of tax, attributable to noncontrolling interest (11)25(48)   
Other undisclosed comprehensive income, net of tax, attributable to parent   48   
Comprehensive income (loss), net of tax, attributable to parent:7,5353,305(5)2,0931,8204016,479

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: